← Open Payments lookup

TONIA SOPER: Open Payments

NPI 1720863814 · LISBON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,095 in 55 payments from 11 companies in 2025. Trend: 2023 $139 · 2024 $991 · 2025 $1,095

Food & beverage: $1,095
CompanyPaymentsAmount
Novo Nordisk Inc14$283
GlaxoSmithKline, LLC.9$205
ABBVIE INC.12$182
Lundbeck LLC3$80
Boehringer Ingelheim Pharmaceuticals, Inc.4$70
Astellas Pharma US Inc2$69
Amgen Inc.4$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$54
PFIZER INC.2$39
AstraZeneca Pharmaceuticals LP1$28

Products named: Rybelsus, Ozempic, TRELEGY ELLIPTA, REXULTI, VRAYLAR, UBRELVY, AREXVY, JARDIANCE.

Industry payments across CT — which companies pay providers there.